IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients – a cohort studyGaya Spolverato, Salvatore Pucciarelli, Giovanni Pirozzolo et al.|International Journal of Surgery|2023Cited by 11
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Chiara Cipollari, Melania Scarpa et al.|Cancer|2024Cited by 8
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Monica Ortenzi, Matteo Fassan et al.|British journal of surgery|2023Cited by 4
IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancerGiulia Becherucci, Daunia Verdi, Cesare Ruffolo et al.|Surgery|2024Cited by 2
1023: IMMUNOREACT 6: YOUNG PATIENTS WITH RECTAL CANCER HAVE A LOWER INFILTRATION OF CD4+ T CELLS WITHIN THE HEALTY RECTAL MUCOSA BUT NO MISMATCH REPAIR GENES DEFECTS.Gaya Spolverato, Marco Scarpa, Matteo Fassan et al.|Gastroenterology|2022Cited by 0